Publication Build: This will be filled in by the publication tooling
Generated Narrative
status: completed
category: Outpatient
medication: doxorubicin hydrochloride 20 MG per 10 ML Injection
effective: 2018-04-22
| - | Actor |
| * | Generated Summary: id: 55667788; Nancy Nurse ; gender: female |
reasonReference: Generated Summary: Remission; Confirmed; Problem List Item; Primary malignant neoplasm of female left breast (disorder); onset: 2018-03-16
request: Generated Summary: status: active; intent: order; Outpatient; DOXOrubicin; authoredOn: 2018-04-12
note: doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)
| - | Route | Dose |
| * | Intravenous route (qualifier value) | 105.96 mg |